Literature DB >> 15048851

BDNF-dependent stimulation of dopamine D5 receptor expression in developing striatal astrocytes involves PI3-kinase signaling.

Veronica Brito1, Cordian Beyer, Eva Küppers.   

Abstract

It is well known that brain-derived neurotrophic factor (BDNF) and the early nigrostriatal dopaminergic input are implicated in the regulation of developmental processes in the neostriatum. There is growing evidence that interactions between these developmental signals rather than singular actions are critical for cellular differentiation and compartmentation of the striatum. In the present report, our goal is to identify striatal target cells for BDNF and dopamine. Using primary neuronal and astroglial cell cultures, we have demonstrated that BDNF selectively regulates D(5) but not D(1) receptor expression in astrocytes. This effect was not observed in neurons. Pharmacological approaches indicated that BDNF effects on dopamine D(5) receptor expression were mediated at the intracellular level by an activation of the PI3- but not MAP-kinase cascade. FACS analysis and confocal laser microscopy revealed that the newly synthesized D(5) receptors were integrated into the plasma membrane of astrocytes. Our findings clearly show that developing striatal astrocytes are targets for BDNF. Furthermore, BDNF appears to regulate the dopamine responsiveness of astrocytes. This implicates that functional interactions between BDNF, dopamine, and astrocytes are necessary to warrant proper differentiation of the striatal anlage. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15048851     DOI: 10.1002/glia.10356

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  8 in total

1.  Quantification of D1 and D5 dopamine receptor localization in layers I, III, and V of Macaca mulatta prefrontal cortical area 9: coexpression in dendritic spines and axon terminals.

Authors:  Jill R Bordelon-Glausier; Zafar U Khan; E Chris Muly
Journal:  J Comp Neurol       Date:  2008-06-20       Impact factor: 3.215

Review 2.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Maiken Nedergaard
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

Review 3.  Volume Transmission in Central Dopamine and Noradrenaline Neurons and Its Astroglial Targets.

Authors:  Kjell Fuxe; Luigi F Agnati; Manuela Marcoli; Dasiel O Borroto-Escuela
Journal:  Neurochem Res       Date:  2015-04-17       Impact factor: 3.996

4.  Small-molecule XIAP inhibitors enhance gamma-irradiation-induced apoptosis in glioblastoma.

Authors:  Sri Hari Krishna Vellanki; Andreas Grabrucker; Stefan Liebau; Christian Proepper; Adriana Eramo; Veit Braun; Tobias Boeckers; Klaus-Michael Debatin; Simone Fulda
Journal:  Neoplasia       Date:  2009-08       Impact factor: 5.715

5.  Dopamine regulates the expression of the glutamate transporter GLT1 but not GLAST in developing striatal astrocytes.

Authors:  Veronica I Brito; Verena E Rozanski; Cordian Beyer; Eva Küppers
Journal:  J Mol Neurosci       Date:  2009-08-15       Impact factor: 3.444

Review 6.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Vladimir Parpura; Nina Vardjan; Robert Zorec
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

7.  Dopamine-Evoked Synaptic Regulation in the Nucleus Accumbens Requires Astrocyte Activity.

Authors:  Michelle Corkrum; Ana Covelo; Justin Lines; Luigi Bellocchio; Marc Pisansky; Kelvin Loke; Ruth Quintana; Patrick E Rothwell; Rafael Lujan; Giovanni Marsicano; Eduardo D Martin; Mark J Thomas; Paulo Kofuji; Alfonso Araque
Journal:  Neuron       Date:  2020-01-15       Impact factor: 17.173

8.  Dopamine Receptor Activation Modulates the Integrity of the Perisynaptic Extracellular Matrix at Excitatory Synapses.

Authors:  Jessica Mitlöhner; Rahul Kaushik; Hartmut Niekisch; Armand Blondiaux; Christine E Gee; Max F K Happel; Eckart Gundelfinger; Alexander Dityatev; Renato Frischknecht; Constanze Seidenbecher
Journal:  Cells       Date:  2020-01-21       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.